Agilent Technologies (LTS:0HAV) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HAV Agilent Technologies Inc LTS:0HAV
95 GF Score
Price $134.19
GF Value $146.03
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Agilent Technologies FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0HAV
95GF Score
Agilent Technologies Inc LTS:0HAV
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Agilent Technologies (LTS:0HAV) Overvalued in 2026?

Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued. The current stock price of $134.19 is trading 8.1% below its estimated GF Value™ of $146.03. GuruFocus considers Agilent Technologies to be Fairly Valued.

Key valuation signals for LTS:0HAV:

  • FFO:
  • GF Value™: $146.03 vs. price of $134.19 (8.1% below fair value)
  • GF Score™: 95/100 with 1 warning sign

No single metric tells the full story. See the LTS:0HAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilent Technologies Business Description

Address 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
95GF Score

Get the complete analysis for LTS:0HAV

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$134.19
Price
$146.03
GF Value